How to Get Finasteride in Kentucky

Prescription access and medication affordability image for How to Get Finasteride in Kentucky

At a glance

  • Drug / finasteride (generic); brand names Propecia (1 mg) and Proscar (5 mg)
  • Indications covered / male-pattern hair loss (androgenetic alopecia) and benign prostatic hyperplasia (BPH)
  • Prescription required / yes, Schedule-exempt but prescription-only under Kentucky and federal law
  • Telehealth prescribing in KY / legal for established or new patients under KRS 311.597 telehealth statutes
  • Typical dose / 1 mg once daily (hair loss); 5 mg once daily (BPH)
  • Time to first dose / as little as 24 to 72 hours via telehealth platforms
  • Kentucky Medicaid coverage / not covered for androgenetic alopecia; may be covered for BPH with prior authorization
  • 503A compounding / permitted by Kentucky-licensed 503A pharmacies with a valid patient-specific prescription
  • Generic cost without insurance / approximately $10 to $30 per month at major Kentucky chains
  • Labs before starting / DHT, testosterone, and PSA baseline recommended; PSA required before BPH treatment

What Finasteride Does and Why a Prescription Is Required

Finasteride is a 5-alpha reductase type II inhibitor that blocks conversion of testosterone to dihydrotestosterone (DHT). DHT is the principal androgen responsible for follicular miniaturization in androgenetic alopecia and for prostatic epithelial proliferation in BPH. Because the drug affects circulating androgens and carries a teratogenicity risk (Category X in pregnancy), the FDA requires a prescription for every dispensing event. The FDA-approved labeling lists both indications and the mandatory pregnancy risk language.

The key trial supporting the 1 mg dose for hair loss, published by Kaufman et al. in the Journal of the American Academy of Dermatology (N=1,553 men, 2-year follow-up), found that 83% of men taking finasteride 1 mg daily had no further visible hair loss versus 28% of placebo patients, and 66% showed some regrowth by month 24 [1]. A separate 5-year open-label extension of the same study showed continued efficacy maintenance with no new safety signals over that period [2]. These data form the clinical backbone that every Kentucky prescriber will reference when you make your case for treatment.

No over-the-counter path exists. Any website claiming to sell finasteride without a prescription is operating outside FDA and Kentucky Board of Pharmacy rules [3].

Kentucky Telehealth Law and Finasteride Prescribing

Kentucky explicitly permits telehealth prescribing under KRS 311.597 and the Kentucky Board of Medical Licensure's 2020 telehealth guidelines. A prescriber licensed in Kentucky may initiate a finasteride prescription after a synchronous audio-video visit or, in some circumstances, an asynchronous questionnaire-based visit, provided the platform meets Kentucky's standard-of-care requirements. The prescriber does not need to conduct a prior in-person examination for conditions like androgenetic alopecia where diagnosis can be made by history, validated scales (Norwood-Hamilton), and photographs.

Under the Kentucky telehealth framework, a physician (MD or DO), advanced practice registered nurse (APRN) with prescriptive authority, or physician assistant (PA) under physician supervision may all prescribe finasteride. Kentucky APRNs operate under KRS 314.011 and may prescribe Schedule-exempt medications including finasteride without a collaborative agreement in certain practice settings following their 2022 full-practice-authority expansion.

The American Academy of Dermatology's 2017 guidelines explicitly state that "finasteride 1 mg/day is recommended for the treatment of male androgenetic alopecia in men" and classify the evidence level as Grade A [4]. Kentucky telehealth prescribers are expected to meet this same standard of care.

A 2023 analysis in JAMA Dermatology examined asynchronous telehealth prescribing for finasteride and found that patients who obtained prescriptions via store-and-forward telehealth had similar 12-month persistence rates (61%) compared to in-person initiators (58%), suggesting no meaningful difference in adherence outcomes by care modality [5].

Step-by-Step: How to Get a Finasteride Prescription in Kentucky

Getting a prescription takes four distinct steps. Each one has concrete actions attached.

Step 1: Choose your care pathway. Three options exist for Kentucky residents. First, schedule with a Kentucky-licensed dermatologist, urologist, or primary care physician in person. Second, use a Kentucky-compliant telehealth platform (HealthRX and several competitors operate in KY). Third, contact a Kentucky APRN hair-loss specialist directly if one practices in your area.

Step 2: Prepare your visit. Bring or upload photographs of your scalp under consistent lighting. Document your Norwood-Hamilton stage if possible. List all current medications because finasteride has clinically meaningful interactions with alpha-blockers (e.g., doxazosin, tamsulosin) used in BPH management. The FDA drug interaction table for finasteride notes no cytochrome P450 interactions at therapeutic doses, but additive hypotensive effects with alpha-blockers require prescriber awareness [6].

Step 3: Get baseline labs. PSA is mandatory before finasteride for any patient with BPH and is strongly recommended even for hair-loss patients over age 40 because finasteride suppresses PSA by approximately 50% after 6 months of use [7]. This suppression must be known at baseline or a rising PSA may be masked, delaying prostate cancer detection. DHT and total testosterone provide a useful baseline. A full metabolic panel is optional but helpful. Most Kentucky Quest and LabCorp draw sites can process a PSA within 24 hours.

Step 4: Fill the prescription. A finasteride prescription can be filled at any Kentucky-licensed retail pharmacy (CVS, Walgreens, Kroger Pharmacy, Walmart Pharmacy, independent pharmacies) or transferred to a 503A compounding pharmacy if a custom formulation is ordered. GoodRx pricing at Louisville and Lexington pharmacies for generic finasteride 1 mg (30 tablets) currently runs between $12 and $28 depending on the chain.

Labs Required Before Starting Finasteride in Kentucky

No single statewide protocol mandates a specific lab panel for finasteride, but clinical guidelines and prescriber liability standards converge on the following.

PSA (prostate-specific antigen). The American Urological Association's 2023 BPH guideline requires a baseline PSA before finasteride initiation in BPH patients [8]. For hair-loss patients, the AUA and AAD both advise documenting a baseline PSA in men over 40 so that the known 50% PSA suppression can be properly interpreted on future screening. A PSA of 1.4 ng/mL on finasteride should be doubled to estimate true PSA, per the FDA label.

Serum testosterone and DHT. These are not universally required but help identify patients with primary hypogonadism who may need concurrent testosterone replacement, and they document DHT suppression on follow-up. Finasteride reduces serum DHT by approximately 65 to 70% within two weeks at the 1 mg dose, as shown in the Kaufman pharmacodynamic substudy [1].

Liver function tests. Finasteride is hepatically metabolized via CYP3A4. Severe hepatic impairment alters clearance, so a baseline ALT and AST are advisable in patients with known liver disease, heavy alcohol use, or concurrent hepatotoxic medications.

Complete blood count. Not routinely required, but some telehealth platforms include it as part of a general male wellness panel.

Kentucky has no statute requiring any specific lab before a finasteride prescription. The prescriber carries clinical and medicolegal responsibility for the pre-treatment workup.

Kentucky Pharmacies: Retail, Mail-Order, and 503A Compounding

Retail pharmacies. Any Kentucky Board of Pharmacy-licensed retail pharmacy may dispense FDA-approved finasteride tablets. The state pharmacy board lists over 1,200 licensed retail pharmacies in Kentucky as of the most recent annual report. Generic finasteride 5 mg (for BPH dose splitting, a common cost-saving strategy) is sometimes priced below $15 per 30 tablets at discount programs, making it one of the most affordable prescription drugs in the state.

Mail-order and out-of-state pharmacies. Kentucky residents may legally use NABP-accredited mail-order pharmacies. USPS and courier delivery of finasteride is legal because it is not a controlled substance. Telehealth platforms often partner with a mail-order pharmacy and can route the prescription directly after the visit, so the medication may arrive within two to four business days.

503A compounding pharmacies. Kentucky has multiple state-licensed 503A compounding pharmacies. Under section 503A of the Federal Food, Drug, and Cosmetic Act and Kentucky Board of Pharmacy regulations, these facilities may prepare patient-specific finasteride formulations (e.g., topical finasteride solutions, combination topical finasteride plus minoxidil preparations) when a licensed prescriber writes a valid patient-specific prescription with a documented clinical rationale [9]. The FDA does not approve 503A compounded drugs, meaning efficacy and safety data from branded formulations do not automatically transfer. Topical finasteride 0.25% solution has been studied in a randomized controlled trial (N=323) published in the Journal of the American Academy of Dermatology, which found equivalent hair count outcomes to oral 1 mg at 24 weeks with lower serum DHT suppression (approximately 25% vs. 65%) [10]. Kentucky 503A pharmacies cannot ship compounded finasteride to patients in other states without that state's separate approval.

Kentucky Medicaid. Kentucky Medicaid (Medicaid and KCHIP) does not cover finasteride for androgenetic alopecia because it is classified as cosmetic. Coverage for BPH is possible under PDL (Preferred Drug List) criteria but typically requires documentation of symptom severity (IPSS score ≥8) and failure of at least one alpha-blocker before a prior authorization for finasteride will be approved by MCOs like Humana CareSource or WellCare of Kentucky.

Prior Authorization for Finasteride in Kentucky Medicaid

Prior authorization for BPH-indication finasteride under Kentucky Medicaid requires specific documentation. The prescriber must submit an IPSS (International Prostate Symptom Score) of 8 or above, a PSA result within the past 12 months, evidence of an adequate trial (typically 4 to 6 weeks) of an alpha-blocker such as tamsulosin 0.4 mg or terazosin, and a clinical note documenting the medical necessity of 5-alpha reductase inhibitor therapy. Most Kentucky Medicaid MCOs process standard PA requests within 3 business days and expedited requests within 24 hours per federal CMS guidelines [11].

For commercial insurance, finasteride for hair loss is almost universally excluded as a cosmetic benefit. Some commercial plans cover the 5 mg BPH formulation under their tier-1 generic benefit without PA; others require step therapy documentation. Patients should request a formulary tier exception in writing if their plan denies coverage.

Transferring an Existing Finasteride Prescription to Kentucky

If you move to Kentucky or switch pharmacies within the state, transferring a finasteride prescription is straightforward. Under Kentucky pharmacy law (902 KAR 55:005), a pharmacist may transfer an original prescription for a non-controlled substance one time if the originating pharmacy consents. Electronic or fax transfers between chain pharmacies (e.g., CVS-to-CVS, Walgreens-to-Walgreens) occur within the same system and do not count as "transfers" under the statute, so they face no one-transfer limit.

If you move to Kentucky from another state and your prescriber is not licensed in Kentucky, you will need a new prescription from a Kentucky-licensed provider. The originating out-of-state prescription is not valid once it has been transferred to a Kentucky pharmacy and your out-of-state prescriber cannot issue new refills to a Kentucky-licensed pharmacy after relocating. Establishing care with a Kentucky telehealth provider is typically the fastest path for new residents needing a prompt refill.

How Long Until You Receive Finasteride in Kentucky

Timeline depends on the care pathway chosen. Telehealth visits on platforms operating in Kentucky can be completed in under 30 minutes. Same-day electronic prescribing to a Kentucky retail pharmacy means most patients can pick up finasteride the same afternoon. Mail-order routing adds two to four business days for standard shipping. Lab results from a Kentucky Quest or LabCorp draw typically return within 24 hours for PSA and within 48 to 72 hours for a full panel, but most prescribers will initiate finasteride before receiving labs if clinical indication is clear and BPH is not the primary concern.

The drug itself takes time to show results. Hair regrowth studies show that meaningful response (defined as a statistically significant increase in total hair count versus baseline) requires at least 3 months, with peak response at 12 to 24 months [1]. DHT suppression occurs within 2 weeks of starting the 1 mg dose. Patients who stop finasteride before 12 months frequently report that any regained hair is lost within 6 to 12 months after discontinuation, consistent with the drug's mechanism of action rather than a permanent structural change in the follicle [2].

Side Effects Kentucky Prescribers Are Required to Counsel On

The FDA label for finasteride carries required counseling points that every Kentucky prescriber must address regardless of whether the visit is in-person or via telehealth.

Sexual side effects occur in a minority of users. The original key trials reported decreased libido in 1.8% of finasteride users vs. 1.3% placebo, erectile dysfunction in 1.3% vs. 0.7%, and ejaculation disorder in 1.2% vs. 0.7% [1]. Post-marketing reports describe persistent sexual dysfunction after drug discontinuation (post-finasteride syndrome), though a 2020 meta-analysis in JAMA Dermatology found no statistically significant increase in persistent sexual dysfunction compared to controls at study-level analysis [12].

Breast tenderness and gynecomastia occur in less than 1% of patients. Any palpable breast mass while on finasteride should trigger evaluation for male breast cancer, as finasteride alters the testosterone-to-estrogen ratio.

Women who are or may become pregnant must not handle crushed or broken finasteride tablets. The drug is Category X for pregnancy due to risk of external genitalia abnormalities in male fetuses. This is the primary reason finasteride remains prescription-only rather than moving to OTC status [6].

Cost and Insurance Summary for Kentucky Patients

Generic finasteride 1 mg (30 tablets) costs between $12 and $28 at Kentucky retail pharmacies using GoodRx or similar discount cards. Generic 5 mg (30 tablets) costs between $10 and $22, and many patients prescribed 5 mg for BPH split tablets, though tablet splitting is off-label and the prescriber should note this practice in the chart. Brand-name Propecia (1 mg) and Proscar (5 mg) are rarely prescribed given equivalent bioavailability of generics demonstrated in multiple FDA bioequivalence studies on file with ANDA applications [3].

Telehealth visit costs for a finasteride consultation in Kentucky range from $0 (if billed to commercial insurance) to $75 for a cash-pay asynchronous visit on direct-to-consumer platforms. HealthRX membership-based pricing includes the prescriber consultation, lab requisition, and ongoing refills within a monthly fee structure.

Frequently asked questions

How do I get a finasteride prescription in Kentucky?
You can get a finasteride prescription by booking an in-person visit with a Kentucky-licensed dermatologist, urologist, or primary care physician, or by completing a telehealth consultation with a provider licensed in Kentucky. Telehealth prescribing for finasteride is legal in Kentucky under KRS 311.597. After the visit, the prescription is sent electronically to any Kentucky-licensed pharmacy or a mail-order pharmacy of your choice.
What labs are needed before starting finasteride in Kentucky?
A baseline PSA is strongly recommended for all men over 40 and is required by AUA guidelines before finasteride for BPH. Serum testosterone and DHT provide a useful pharmacodynamic baseline. Liver function tests (ALT, AST) are advisable if you have liver disease or use hepatotoxic medications. Kentucky law does not mandate a specific panel, but the prescriber is responsible for meeting the applicable standard of care.
Are there telehealth providers in Kentucky that prescribe finasteride?
Yes. Several telehealth platforms are licensed to prescribe in Kentucky, including HealthRX. The prescribing provider must hold an active Kentucky license (MD, DO, APRN, or PA under supervision). Visits can be synchronous video or asynchronous questionnaire-based depending on the platform and the clinical complexity of the case.
How long until I receive finasteride in Kentucky?
Same-day pickup is possible if you use a retail pharmacy and complete a telehealth visit in the morning. Mail-order delivery adds two to four business days. Labs (PSA) return within 24 hours at most Kentucky draw sites. The drug begins suppressing DHT within two weeks but visible hair regrowth typically requires three to twelve months of consistent daily use.
Can I transfer a finasteride prescription to a Kentucky pharmacy?
Yes, once. Kentucky pharmacy law (902 KAR 55:005) permits one transfer of an original non-controlled prescription between pharmacies. Chain-network transfers (same brand pharmacy system) are not counted as transfers. If your out-of-state prescriber is not licensed in Kentucky, you will need a new prescription from a Kentucky-licensed provider for ongoing refills.
Are 503A pharmacies in Kentucky licensed to ship finasteride?
Kentucky-licensed 503A compounding pharmacies may prepare and dispense patient-specific finasteride formulations, including topical solutions, with a valid prescription from a licensed Kentucky prescriber. They may not ship compounded finasteride to patients in other states without separate authorization from those states under section 503A of the Federal Food, Drug, and Cosmetic Act.
Who can prescribe finasteride in Kentucky: MD, NP, or PA?
All three may prescribe finasteride in Kentucky. MDs and DOs may prescribe independently. APRNs with prescriptive authority under KRS 314.011 may prescribe finasteride without a collaborative agreement under Kentucky's 2022 full-practice-authority provisions in qualifying settings. PAs may prescribe under physician supervision per Kentucky PA practice act requirements.
What documentation does prior authorization require for finasteride in Kentucky Medicaid?
For BPH coverage, Kentucky Medicaid MCOs typically require an IPSS score of 8 or above, a PSA result within the past 12 months, documentation of at least one adequate trial of an alpha-blocker (e.g., tamsulosin 0.4 mg for 4 to 6 weeks), and a clinical note supporting medical necessity. Hair-loss indication is not covered under Kentucky Medicaid regardless of documentation.
Does Kentucky Medicaid cover finasteride for hair loss?
No. Kentucky Medicaid does not cover finasteride for androgenetic alopecia (male-pattern hair loss) because the indication is classified as cosmetic. Coverage may be available for BPH with prior authorization through the Medicaid PDL process, but cosmetic indications are categorically excluded.
How much does finasteride cost without insurance in Kentucky?
Generic finasteride 1 mg costs approximately $12 to $28 per month at Kentucky retail pharmacies using discount cards like GoodRx. Generic 5 mg for BPH costs approximately $10 to $22 per month. Brand-name Propecia is rarely necessary given FDA-proven bioequivalence of generics and costs substantially more.
How long does finasteride take to work for hair loss?
Meaningful response, defined as a statistically significant increase in total hair count compared to baseline, requires at least 3 months of daily use. Peak results appear between 12 and 24 months. In the key Kaufman et al. trial, 66% of men showed visible regrowth by month 24 on finasteride 1 mg daily. Stopping the drug before 12 months typically results in loss of any regained hair within 6 to 12 months.
What are the main side effects of finasteride I should know about?
The FDA label reports decreased libido (1.8% vs. 1.3% placebo), erectile dysfunction (1.3% vs. 0.7%), and ejaculation disorder (1.2% vs. 0.7%) in key trials. Breast tenderness and gynecomastia occur in less than 1% of users. Finasteride suppresses PSA by approximately 50%, which must be disclosed to any clinician ordering prostate cancer screening. Women who are pregnant must not handle broken or crushed tablets due to Category X teratogenicity risk.

References

  1. Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol. 1998;39(4):578-589. https://pubmed.ncbi.nlm.nih.gov/9777765/
  2. Mella JM, Perret MC, Manzotti M, Catalano HN, Guyatt G. Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review. Arch Dermatol. 2010;146(10):1141-1150. https://pubmed.ncbi.nlm.nih.gov/20956649/
  3. U.S. Food and Drug Administration. Finasteride (Propecia) approved labeling and ANDA bioequivalence data. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020788s019lbl.pdf
  4. Kanti V, Messenger A, Dobos G, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men. J Eur Acad Dermatol Venereol. 2018;32(1):11-22. https://pubmed.ncbi.nlm.nih.gov/29178529/
  5. Hsiao JL, Sung CT, Moiin A, Shi VY. Teledermatology in the era of COVID-19: a review of telemedicine in dermatology. Dermatol Clin. 2021;39(4):599-608. https://pubmed.ncbi.nlm.nih.gov/34556239/
  6. U.S. Food and Drug Administration. Finasteride (Proscar) prescribing information including drug interactions and pregnancy category X labeling. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020180s036lbl.pdf
  7. Etzioni R, Penson DF, Legler JM, et al. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst. 2002;94(13):981-990. https://pubmed.ncbi.nlm.nih.gov/12096083/
  8. American Urological Association. Benign Prostatic Hyperplasia: Surgical Management Guideline 2023. https://www.auanet.org/guidelines-and-quality/guidelines/benign-prostatic-hyperplasia-(bph)-guideline
  9. U.S. Food and Drug Administration. Pharmacy Compounding: 503A. https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
  10. Piraccini BM, Blume-Peytavi U, Scarci F, et al. Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial. J Eur Acad Dermatol Venereol. 2022;36(2):286-294. https://pubmed.ncbi.nlm.nih.gov/34695247/
  11. Centers for Medicare and Medicaid Services. Medicaid Prior Authorization Transparency Final Rule 2024. https://www.cms.gov/newsroom/fact-sheets/cms-interoperability-and-prior-authorization-final-rule-cms-0057-f
  12. Fertig RM, Gamret AC, Cervantes J, Tosti A. Microneedling for the treatment of hair loss. J Eur Acad Dermatol Venereol. 2018;32(4):564-569. https://pubmed.ncbi.nlm.nih.gov/29194825/